2
Views
0
CrossRef citations to date
0
Altmetric
Articles

Tumour necrosis factor-alpha in diastolic dysfunction

, , , , &
Pages 507-510 | Received 22 Jul 2003, Accepted 13 Jan 2004, Published online: 23 May 2017

References

  • Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Ele-vated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236–41.
  • McMurray J, Abdullah I, Dargie HJ, Shapiro D. Increased concentrations of tumor necrosis factor in `cachectic’ patients with severe chronic heart failure. Br Heart J1991; 66: 356–8.
  • Dutka DP, Elborn JS, Delamere F, Shale DJ, Morris GK. Tumor necrosis factor a in severe congestive cardiac failure. Br Heart J1993; 70: 141–3.
  • Maury CPJ, Teppo AM. Circulating tumor necrosis factor-a (cachectin) in myocardial infarction. J Intern Med 1989; 225: 333–336.
  • Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J1994; 72: 561–6.
  • Francis GS. TNF-a and heart failure. The difference between proof of principle and hypothesis testing. Circulation 1999; 99: 3213–4.
  • Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-a in the adult mammalian cardiac myocyte. J Clin Invest 1993; 92: 2303–12.
  • Goldhaber JI, Kim KH, Natterson PD, Lawrence T, Yang P, Weiss JN. Effects of TNF-a on [Ca2] and contractility in isolated adult rabbit ventricular myocytes. Am J Physiol 1996; 271: H1449–H1455.
  • Krown KA, Yasui K, Brooker MJ, Dubin AE, Nguyen C, Harris GL, McDonough PM, Glembotski CC, Palade PT, Sabbadini RA. TNF-a receptor expression in rat cardiac myocytes: TNF inhibition of L-type Ca2+ current and Ca2+ transients. FEBS Lett 1995; 376: 24–30.
  • Klein AL, Scalia GM. Disease of pericardium, restrictive cardiomyopathy and diastolic dysfunction. In: Topol EJ, Ed. Textbook of Cardiovascular Medicine. Lippincott-Raven Publishers, Philadelphia 1998; 639–705.
  • Meldrum DR, Cleveland JC Jr, Sheridan BC, Rowland RT, Banerjee A, Harken AH. Cardiac surgical implications of calcium dyshomeostasis in the heart. Ann Thorac Surg 1996; 61:1273–80.
  • Feldman AM, Combes A, Wagner D, Kadakomi T, Kubota T, Li YY, McTiernan C. The role of tumor necro-sis factor in the pathophysiology of heart failure. J Am Coll Cardiol 2000; 35: 537–44.
  • Schiller NB, Shah PM, Crawford M, DeMaria A, Deve-reux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, Silverman NH, Tajik AJ. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2: 358–67.
  • Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assess-ment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450–8.
  • Vandenberg BF, Cardona H, Miller JG, Burns TL, Skor-ton DJ, Perez JE. Estimation of left ventricular ejection frac-tion by semiautomated edge detection. Echocardiography 1998; 15: 713–20.
  • Klein AL, Burstow DJ, Tajik AJ, Zachariah PK, Bailey KR, Seward JB. Effects of age on left ventricular dimensions and filling dynamics in 117 normal persons. Mayo Clin Proc 1994; 69: 212–24.
  • Sohn DW, Chai IH, Lee DJ, Kim HC, Kim HS, Oh BH, Lee MM, Park YB, Choi YS, Seo JD, Lee YIN. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997; 30: 474–80.
  • Meldrum DR, Tumor necrosis factor in the heart. Am J Physiol 1998; 274: R577–R595.
  • DeMeules JE, Pigula FA, Mueller M, Raymond SJ, Gamelli RL. Tumor necrosis factor and cardiac function. J Trauma 1992; 32: 686–92.
  • Cain BS, Meldrum DR, Dinarello CA, Meng X, Joo KS, Banerjee A, Harken AH. Tumor necrosis factor-alpha and interleukin-lbeta synergistically depress human myocardial function. Crit Care Med 1999; 27: 1309–18.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.